PRICE T ROWE ASSOCIATES INC /MD/ - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 170 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q2 2023$63
-26.7%
122,000
-10.2%
0.00%
Q1 2023$86
+50.9%
135,834
+53.4%
0.00%
Q4 2022$57
-100.0%
88,5340.0%0.00%
Q3 2022$153,000
+24.4%
88,534
-10.9%
0.00%
Q2 2022$123,000
+43.0%
99,400
-24.6%
0.00%
Q1 2022$86,000
-30.6%
131,836
+15.7%
0.00%
Q4 2021$124,000
-70.4%
113,936
-50.6%
0.00%
Q3 2021$419,000
+54.0%
230,436
+123.9%
0.00%
Q2 2021$272,000
-20.2%
102,936
+8.8%
0.00%
Q1 2021$341,000
+25.4%
94,605
-12.4%
0.00%
Q4 2020$272,000
-0.7%
107,954
-0.7%
0.00%
Q3 2020$274,000
-23.2%
108,7540.0%0.00%
Q2 2020$357,000
+36.8%
108,754
+2.1%
0.00%
Q1 2020$261,000
-46.1%
106,497
+3.9%
0.00%
Q4 2019$484,000
+21.0%
102,524
+9.7%
0.00%
Q3 2019$400,000
-25.9%
93,463
+0.8%
0.00%
Q2 2019$540,000
+52.5%
92,680
+0.9%
0.00%
Q1 2019$354,000
+107.0%
91,877
+0.4%
0.00%
Q4 2018$171,000
-49.9%
91,477
-14.2%
0.00%
Q3 2018$341,000
+45.7%
106,556
+37.7%
0.00%
Q2 2018$234,000
-22.0%
77,368
+1.1%
0.00%
Q1 2018$300,000
+30.4%
76,525
+37.7%
0.00%
Q4 2017$230,000
-44.2%
55,569
-17.3%
0.00%
Q3 2017$412,000
+28.3%
67,169
+30.0%
0.00%
Q2 2017$321,000
-22.5%
51,669
-20.8%
0.00%
Q1 2017$414,000
+18.6%
65,2350.0%0.00%
Q4 2016$349,000
-4.9%
65,235
+0.1%
0.00%
Q3 2016$367,000
+2.5%
65,2000.0%0.00%
Q2 2016$358,000
-7.7%
65,200
+24.7%
0.00%
Q1 2016$388,000
-10.8%
52,3000.0%0.00%
Q4 2015$435,000
-47.8%
52,300
-43.5%
0.00%
Q3 2015$833,000
-15.2%
92,500
+13.1%
0.00%
Q2 2015$982,000
+81.5%
81,800
+62.9%
0.00%
Q1 2015$541,000
+69.1%
50,200
-20.6%
0.00%
Q4 2014$320,000
+91.6%
63,2000.0%0.00%
Q3 2014$167,000
-3.5%
63,200
+47.0%
0.00%
Q2 2014$173,000
-12.2%
43,0000.0%0.00%
Q1 2014$197,000
-47.3%
43,000
-50.0%
0.00%
Q4 2013$374,00086,0000.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 12,546,493$22,835,0001.71%
MSD Partners, L.P. 15,151,516$27,576,0000.84%
MSD Partners, L.P. 7,575,758$13,788,0000.42%
CHIRON CAPITAL MANAGEMENT, LLC 198,002$360,0000.26%
Avidity Partners Management LP 3,000,000$5,460,0000.12%
Old West Investment Management, LLC 211,513$384,0000.10%
MAGNOLIA CAPITAL ADVISORS LLC 103,239$188,0000.07%
Virtus ETF Advisers LLC 72,060$131,0000.06%
ACT WEALTH MANAGEMENT, LLC 34,454$91,0000.06%
Allred Capital Management, LLC 53,000$96,0000.05%
View complete list of ZIOPHARM ONCOLOGY INC shareholders